Related Experiment Videos
Summary
Surgery for glomus jugulare tumors led to high recurrence rates (70%). Radiation therapy, used as primary or adjuvant treatment, demonstrated effectiveness in managing recurrent disease in this retrospective review.
Area of Science:
- Neuro-oncology
- Surgical oncology
- Radiation oncology
Background:
- Glomus jugulare tumors, a type of paraganglioma, arise from the skull base.
- These tumors can cause significant morbidity due to their location and potential for growth.
Purpose of the Study:
- To evaluate treatment outcomes for glomus jugulare tumors.
- To assess recurrence rates after surgery and the efficacy of radiation therapy.
Main Methods:
- Retrospective review of 17 patients diagnosed with glomus jugulare tumors.
- Analysis of primary treatment (surgery), adjuvant/primary radiation therapy, and recurrence patterns.
Main Results:
- Surgery was the primary treatment in 15/17 patients, with a 70% recurrence rate.
- Radiation therapy was administered to 11 patients, including for recurrent disease, with doses ranging from 2200 to 5600 rad.
- 16/17 patients had disease controlled at follow-up (2-22 years).
Conclusions:
- Surgery for glomus jugulare tumors is associated with high recurrence rates.
- Radiation therapy appears effective in managing recurrent glomus jugulare tumors.
- Multimodal treatment approaches may be necessary for optimal patient outcomes.